Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Cilloni

Showing results (21-30 of 193) with videos related to

Pageof 20
Sort By:
Current Hematologic Malignancy Reports|April 29, 2010
Molecular monitoring in patients with chronic myelogenous leukemiaGiuseppe Saglio, Stefano Ulisciani, Milena Fava, et al.
Haematologica|April 12, 2005
New tyrosine kinase inhibitors in chronic myeloid leukemiaGiovanni Martinelli, Simona Soverini, Gianantonio Rosti, et al.
Internal and Emergency Medicine|July 17, 2008
Herpetic leg paralysis and abdominal ileus in a patient with idiopathic myelofibrosisPaolo Nicoli, Marco Bosa, Antonia Rotolo, et al.
Haematologica|August 2, 2007
Nuclear factor kB as a target for new drug development in myeloid malignanciesDaniela Cilloni, Giovanni Martinelli, Francesca Messa, et al.
Journal of Clinical Medicine|February 15, 2022
Revealing the Mysteries of Acute Myeloid Leukemia: From Quantitative PCR through Next-Generation Sequencing and Systemic Metabolomic ProfilingCristina Panuzzo, Aleksandar Jovanovski, Muhammad Shahzad Ali, et al.
Leukemia & Lymphoma|September 11, 2019
Synergistic effect of eltrombopag and deferasirox in aplastic anemia: a clinical case and review of the literatureDaniela Cilloni, Giacomo Andreani, Matteo Dragani, et al.
Leukemia & Lymphoma|April 10, 2008
New therapeutic approaches and prognostic factors in chronic myeloid leukemiaGiuseppe Saglio, Stefano Ulisciani, Marco Bosa, et al.
Haematologica|November 21, 2007
Long-term molecular responses to imatinib in patients with chronic myeloid leukemia: comparison between complete cytogenetic responders treated in early and in late chronic phaseFrancesca Palandri, Ilaria Iacobucci, Fabrizio Quarantelli, et al.
American Journal of Hematology|November 16, 2018
Venetoclax plus decitabine induced complete remission with molecular response in acute myeloid leukemia relapsed after hematopoietic stem cell transplantationGiacomo Andreani, Matteo Dragani, Anna Serra, et al.
International Journal of Molecular Sciences|October 26, 2024
Detection of <i>KIT</i> Mutations in Systemic Mastocytosis: How, When, and WhyDaniela Cilloni, Beatrice Maffeo, Arianna Savi, et al.
Pageof 20

Showing results (21-30 of 193) with videos related to

Sort By:
Pageof 20
Current Hematologic Malignancy Reports|April 29, 2010
Molecular monitoring in patients with chronic myelogenous leukemiaGiuseppe Saglio, Stefano Ulisciani, Milena Fava, et al.
Haematologica|April 12, 2005
New tyrosine kinase inhibitors in chronic myeloid leukemiaGiovanni Martinelli, Simona Soverini, Gianantonio Rosti, et al.
Internal and Emergency Medicine|July 17, 2008
Herpetic leg paralysis and abdominal ileus in a patient with idiopathic myelofibrosisPaolo Nicoli, Marco Bosa, Antonia Rotolo, et al.
Haematologica|August 2, 2007
Nuclear factor kB as a target for new drug development in myeloid malignanciesDaniela Cilloni, Giovanni Martinelli, Francesca Messa, et al.
Journal of Clinical Medicine|February 15, 2022
Revealing the Mysteries of Acute Myeloid Leukemia: From Quantitative PCR through Next-Generation Sequencing and Systemic Metabolomic ProfilingCristina Panuzzo, Aleksandar Jovanovski, Muhammad Shahzad Ali, et al.
Leukemia & Lymphoma|September 11, 2019
Synergistic effect of eltrombopag and deferasirox in aplastic anemia: a clinical case and review of the literatureDaniela Cilloni, Giacomo Andreani, Matteo Dragani, et al.
Leukemia & Lymphoma|April 10, 2008
New therapeutic approaches and prognostic factors in chronic myeloid leukemiaGiuseppe Saglio, Stefano Ulisciani, Marco Bosa, et al.
Haematologica|November 21, 2007
Long-term molecular responses to imatinib in patients with chronic myeloid leukemia: comparison between complete cytogenetic responders treated in early and in late chronic phaseFrancesca Palandri, Ilaria Iacobucci, Fabrizio Quarantelli, et al.
American Journal of Hematology|November 16, 2018
Venetoclax plus decitabine induced complete remission with molecular response in acute myeloid leukemia relapsed after hematopoietic stem cell transplantationGiacomo Andreani, Matteo Dragani, Anna Serra, et al.
International Journal of Molecular Sciences|October 26, 2024
Detection of <i>KIT</i> Mutations in Systemic Mastocytosis: How, When, and WhyDaniela Cilloni, Beatrice Maffeo, Arianna Savi, et al.
Pageof 20